These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33338679)

  • 21. A Retrospective Comparison of Ahmed Glaucoma Valve Implants with or without Ologen Collagen Matrix.
    Suzuki Junior ER; Maestrini HA; Ruppert ADP; Seixas RCS; Belfort AF; de Miranda Santos HD; Basile Neto A; Balbino M; Lopes da Silva MJ
    Clin Ophthalmol; 2023; 17():15-23. PubMed ID: 36627928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome of low-cost glaucoma drainage device (Aurolab aqueous drainage implant) compared with Ahmed glaucoma valve.
    Pandav SS; Seth NG; Thattaruthody F; Kaur M; Akella M; Vats A; Kaushik S; Raj S
    Br J Ophthalmol; 2020 Apr; 104(4):557-562. PubMed ID: 31272955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ologen augmentation of Ahmed valves in pediatric glaucomas.
    Jacobson A; Bohnsack BL
    J AAPOS; 2022 Jun; 26(3):122.e1-122.e6. PubMed ID: 35550861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up.
    Budenz DL; Barton K; Feuer WJ; Schiffman J; Costa VP; Godfrey DG; Buys YM;
    Ophthalmology; 2011 Mar; 118(3):443-52. PubMed ID: 20932583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Outcome of Intravitreal Bevacizumab Followed by Ahmed Valve Implantation in the Management of Neovascular Glaucoma.
    Tailor R; Kinsella MT; Clarke JC
    Semin Ophthalmol; 2018; 33(5):606-612. PubMed ID: 28992424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of Combined Ahmed Glaucoma Valve and Trabeculectomy Revision With Adjunctive Antimetabolite.
    Lin M; Alizadeh R; Law SK
    J Glaucoma; 2019 May; 28(5):404-410. PubMed ID: 31048638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ahmed glaucoma valve implantation with Ologen
    Park KH; Kim JY; Choo SW; Yoon HY; Jeong SW
    Vet Ophthalmol; 2018 Jan; 21(1):96-100. PubMed ID: 27539152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two Year Randomized Prospective Comparison of Ahmed Valve Versus Baerveldt Implant in Vitrectomized Eyes.
    Kandarakis SA; Petrou P; Katsimpris A; Papakonstantinou E; Timpilis M; Chronopoulou K; Lehman A; Ifantides C; Georgalas I
    J Glaucoma; 2023 Jan; 32(1):27-33. PubMed ID: 36223288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for hypertensive phase after Ahmed glaucoma valve implantation.
    Özalp O; İlgüy S; Atalay E; Şimşek T; Yıldırım N
    Int Ophthalmol; 2022 Jan; 42(1):147-156. PubMed ID: 34420122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year treatment outcomes in the Ahmed Baerveldt comparison study.
    Budenz DL; Barton K; Gedde SJ; Feuer WJ; Schiffman J; Costa VP; Godfrey DG; Buys YM;
    Ophthalmology; 2015 Feb; 122(2):308-16. PubMed ID: 25439606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of Trabeculectomy Augmented With Subconjunctival and Subscleral Ologen Implantation in Primary Advanced Glaucoma.
    Angmo D; Wadhwani M; Upadhyay AD; Temkar S; Dada T
    J Glaucoma; 2017 Jan; 26(1):8-14. PubMed ID: 27599174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the outcome of silicone Ahmed glaucoma valve implantation with a surface area between 96 and 184 mm² in adult eyes.
    Koh KM; Hwang YH; Jung JJ; Sohn YH; Kim HK
    Korean J Ophthalmol; 2013 Oct; 27(5):361-7. PubMed ID: 24082774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors Associated with Outcomes of Combined Phacoemulsification and Ahmed Glaucoma Valve Implantation.
    Kwon J; Sung KR
    Korean J Ophthalmol; 2018 Jun; 32(3):211-220. PubMed ID: 29770636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive triamcinolone acetonide for Ahmed glaucoma valve implantation: a randomized clinical trial.
    Yazdani S; Doozandeh A; Pakravan M; Ownagh V; Yaseri M
    Eur J Ophthalmol; 2017 Jun; 27(4):411-416. PubMed ID: 27791254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review.
    Johnson MS; Sarkisian SR
    J Glaucoma; 2014 Dec; 23(9):649-52. PubMed ID: 24240882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective study on the outcomes of Ahmed valve versus Ahmed valve combined with fluocinolone implant in uveitic glaucoma.
    Sevgi DD; Davoudi S; Talcott KE; Cho H; Guo R; Lobo AM; Papaliodis GN; Turalba A; Sobrin L; Shen LQ
    Digit J Ophthalmol; 2017; 23(3):63-70. PubMed ID: 29162989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tube Shunt Revision With Excision of Fibrotic Capsule Using Mitomycin C With and Without Ologen-a Collagen Matrix Implant: A 3-Year Follow-up Study.
    Salimi A; Kovalyuk N; Harasymowycz PJ
    J Glaucoma; 2019 Nov; 28(11):989-996. PubMed ID: 31567908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Phacoemulsification on Intraocular Pressure in Eyes with Preexisting Glaucoma Drainage Implants.
    Wong SH; Radell JE; Dangda S; Mavrommatis M; Yook E; Vinod K; Sidoti PA; Panarelli JF
    Ophthalmol Glaucoma; 2021; 4(4):350-357. PubMed ID: 33242681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and Outcomes of Hypertensive Phase After Glaucoma Drainage Device Surgery.
    Tang M; Gill N; Tanna AP
    Ophthalmol Glaucoma; 2024; 7(4):345-351. PubMed ID: 38548133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-year treatment outcomes in the Ahmed Baerveldt comparison study.
    Barton K; Feuer WJ; Budenz DL; Schiffman J; Costa VP; Godfrey DG; Buys YM;
    Ophthalmology; 2014 Aug; 121(8):1547-57.e1. PubMed ID: 24768240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.